Literature DB >> 658106

Steady state serum concentrations and renal clearance of digoxin in neonates, infants and children.

H Halkin, M Radomsky, P Millman, S Almog, L Blieden, H Boichis.   

Abstract

Steady state serum concentrations of digoxin were determined repeatedly in 34 infants with congenital heart disease. Simultaneous measurements of renal clearances of digoxin, creatinine and urea were obtained in 29 of the subjects. Serum digoxin concentrations were markedly higher in children under the age of 3 months than in those over this age, despite equal weight--adjusted 24 h doses. This finding was explained by a very rapid increase in renal digoxin clearance in the first 3 months--32 +/- 7 ml/min/1.73m2 at 1 week to 65.6 +/- 30 at 3 months. The subsequent increase in digoxin clearance was much slower, e. g. to 87.7 +/- 43 ml/min/1.73m2 at 12 months. Renal clearance of digoxin was equally well correlated with creatinine clearance (r = 0.87) as with urea clearance (r = 0.83), but it exceeded that of creatinine in all age groups. The findings indicate that both glomerular and tubular function is involved in the renal elimination of digoxin in young children, and that development of renal elimination of the drug parallels that of the maturation of renal function in the early months of life. The neonate and infant with congestive heart failure display impaired ability to eliminate digoxin. The impairment lessens rapidly with the development of renal function over the first 3 months of life. Diminished doses of digoxin should be advocated in this age group if therapeutic serum concentrations of the drug are to be maintained and toxicity avoided.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658106     DOI: 10.1007/BF00609754

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Determinants of the renal clearance of digoxin.

Authors:  H Halkin; L B Sheiner; C C Peck; K L Melmon
Journal:  Clin Pharmacol Ther       Date:  1975-04       Impact factor: 6.875

2.  Fractional excretion of uric acid in infancy and childhood. Index of tubular maturation.

Authors:  J H Passwell; M Modan; M Brish; S Orda; H Boichis
Journal:  Arch Dis Child       Date:  1974-11       Impact factor: 3.791

3.  Renal tubular secretion of digoxin.

Authors:  E Steiness
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

4.  Plasma digoxin levels in infants.

Authors:  K O'Malley; E N Coleman; W B Doig; I H Stevenson
Journal:  Arch Dis Child       Date:  1973-01       Impact factor: 3.791

5.  Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia.

Authors:  J B Dossetor
Journal:  Ann Intern Med       Date:  1966-12       Impact factor: 25.391

6.  A simple empirical formula for calculating approximate surface area in children.

Authors:  H Costeff
Journal:  Arch Dis Child       Date:  1966-12       Impact factor: 3.791

7.  Concentrations of digoxin in plasma and urine in neonates, infants, and children with heart disease.

Authors:  G Wettrell; K E Andersson; A Bertler; N R Lundström
Journal:  Acta Paediatr Scand       Date:  1974-09

8.  Serum levels of digoxin in infants and children.

Authors:  R W Krasula; P A Pellegrino; A R Hastreiter; L F Soyka
Journal:  J Pediatr       Date:  1972-09       Impact factor: 4.406

9.  Steady state serum digoxin concentration in relation to digitalis toxicity in neonates and infants.

Authors:  H Halkin; M Radomsky; L Blieden; M Frand; P Millman; H Boichis
Journal:  Pediatrics       Date:  1978-02       Impact factor: 7.124

10.  Renal tubular handling of drugs.

Authors:  E J Cafruny
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965

View more
  7 in total

1.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 2.  Developmental pharmacokinetics in pediatric populations.

Authors:  Hong Lu; Sara Rosenbaum
Journal:  J Pediatr Pharmacol Ther       Date:  2014 Oct-Dec

Review 3.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors.

Authors:  C Steinberg; D A Notterman
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

5.  The pharmacokinetics of digoxin in newborn and adult sheep.

Authors:  W Berman; J Musselman; R Shortencarrier
Journal:  J Pharmacokinet Biopharm       Date:  1982-04

6.  Dosing Recommendations for Pediatric Patients With Renal Impairment.

Authors:  Amer Al-Khouja; Kyunghun Park; Daijha J C Anderson; Caitlyn Young; Jian Wang; Shiew Mei Huang; Mona Khurana; Gilbert J Burckart
Journal:  J Clin Pharmacol       Date:  2020-06-15       Impact factor: 3.126

7.  Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.

Authors:  Stefan Willmann; Corina Becker; Rolf Burghaus; Katrin Coboeken; Andrea Edginton; Jörg Lippert; Hans-Ulrich Siegmund; Kirstin Thelen; Wolfgang Mück
Journal:  Clin Pharmacokinet       Date:  2014-01       Impact factor: 6.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.